Eli Lilly
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$874
|
$815B |
17.3x |
47.2x |
AbbVie
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
$202
|
$418B |
7.4x |
16.9x |
Johnson & Johnson
|
United States of America |
Biopharmaceuticals,
Medical Devices,
Drug Development & Therapeutics
|
$162
|
$403B |
4.5x |
12.8x |
Novo Nordisk
|
Denmark |
Biopharmaceuticals,
Drug Development & Therapeutics
|
DKK 630
|
$401B |
9.6x |
19.6x |
Roche
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Imaging & Diagnostics
|
CHF 301
|
$293B |
4.3x |
11.2x |
AstraZeneca
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
£116
|
$251B |
4.5x |
13.5x |
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$89
|
$250B |
3.9x |
9.3x |
Novartis
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 98
|
$232B |
4.6x |
11.1x |
Amgen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$303
|
$211B |
6.3x |
10.6x |
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$26
|
$206B |
3.2x |
8.5x |
Gilead Sciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$110
|
$155B |
5.4x |
13.6x |
Bristol-Myers Squibb
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$56
|
$154B |
3.2x |
19.6x |
Sanofi
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€104
|
$146B |
3.1x |
10.8x |
Vertex Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Regenerative Medicine
|
$484
|
$120B |
10.8x |
75.8x |
GSK
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£14
|
$90.8B |
2.3x |
6.5x |
Chugai Pharmaceutical
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 7685
|
$77.0B |
9.9x |
20.2x |
Zoetis
|
United States of America |
Pet Care,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$160
|
$76.6B |
8.3x |
19.4x |
Takeda Pharmaceuticals
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 4218
|
$72.7B |
2.4x |
8.9x |
Merck KGaA
|
Germany |
Biopharmaceuticals,
Drug Development & Therapeutics,
Advanced Materials
|
€136
|
$69.7B |
3.1x |
11.0x |
Bayer
|
Germany |
Biopharmaceuticals,
Agriculture,
Drug Development & Therapeutics,
Health & Beauty
|
€22
|
$55.8B |
1.2x |
5.3x |
Lonza Group
|
Switzerland |
Contract Research & Manufacturing,
Biopharmaceuticals
|
CHF 584
|
$49.8B |
6.7x |
23.1x |
Sun Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1644
|
$43.3B |
7.2x |
25.2x |
Jiangsu Hengrui
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 48
|
$39.1B |
10.4x |
42.4x |
Daiichi Sankyo
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 3429
|
$38.0B |
3.2x |
17.2x |
Teva Pharmaceuticals
|
Israel |
Biopharmaceuticals,
Drug Development & Therapeutics
|
ILS 62
|
$34.8B |
2.1x |
7.1x |
Celltrion
|
South Korea |
Biopharmaceuticals
|
KRW 178200
|
$27.7B |
11.0x |
36.7x |
Viatris
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$11
|
$27.4B |
1.9x |
5.9x |
Biogen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$141
|
$24.8B |
2.6x |
7.5x |
Otsuka Holdings
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
JPY 7194
|
$23.8B |
1.5x |
7.2x |
Bausch Health
|
Canada |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices,
Health & Beauty
|
CAD 10
|
$23.1B |
2.4x |
6.9x |
Astellas Pharma
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 1466
|
$22.0B |
1.8x |
8.9x |
Royalty Pharma
|
United States of America |
Biopharmaceuticals
|
$33
|
$20.3B |
7.2x |
7.8x |
Sandoz
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 42
|
$19.9B |
1.9x |
9.5x |
Grifols
|
Spain |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€8
|
$14.7B |
2.0x |
8.0x |
Alteogen
|
South Korea |
Biopharmaceuticals
|
KRW 392000
|
$14.4B |
222.2x |
822.0x |
Recordati
|
Italy |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€55
|
$13.2B |
5.3x |
14.4x |
Cipla
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1474
|
$12.8B |
4.0x |
15.7x |
Intra-Cellular Therapies
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$129
|
$12.7B |
17.7x |
-143.5x |
Torrent Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 3039
|
$12.0B |
9.1x |
28.1x |
Organon
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$15
|
$12.0B |
1.9x |
6.1x |
Hansoh Pharma
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 20
|
$11.9B |
7.1x |
20.1x |
Yunnan Baiyao Group
|
China |
Biopharmaceuticals,
Health & Beauty
|
CNY 56
|
$11.7B |
2.1x |
15.9x |
Sobi
|
Sweden |
Biopharmaceuticals,
Drug Development & Therapeutics
|
SEK 312
|
$11.5B |
4.6x |
12.8x |
Neurocrine Biosciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$121
|
$11.4B |
4.8x |
17.2x |
Genmab
|
Denmark |
Drug Development & Therapeutics,
Biopharmaceuticals
|
DKK 1583
|
$11.2B |
3.6x |
11.0x |
Fosun Pharma
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
CNY 23
|
$11.2B |
1.9x |
13.1x |
Sichuan Biokin
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 209
|
$11.1B |
14.7x |
22.9x |
Dr. Reddy's Laboratories
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1152
|
$11.0B |
3.0x |
10.9x |
Mankind Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
INR 2327
|
$10.6B |
7.6x |
29.1x |
Lupin
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1906
|
$10.0B |
3.9x |
17.1x |
Zydus Lifesciences
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 885
|
$9.9B |
3.8x |
13.1x |
Zhejiang NHU
|
China |
Biopharmaceuticals,
Nutraceuticals & Cosmeceuticals
|
CNY 22
|
$9.5B |
3.2x |
8.1x |
Shionogi
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
JPY 2257
|
$8.9B |
3.0x |
7.3x |
Ipsen
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€109
|
$8.7B |
2.4x |
6.5x |
Huadong Medicine
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 35
|
$8.2B |
1.4x |
11.9x |
Innovent Biologics
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 42
|
$8.0B |
6.7x |
-176.6x |
Halozyme Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$58
|
$8.0B |
7.7x |
12.3x |
Akeso
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 69
|
$8.0B |
21.9x |
-377.3x |
Orion
|
Finland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€52
|
$7.7B |
4.8x |
16.6x |
Aurobindo Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1115
|
$7.6B |
2.1x |
9.9x |
Eisai Co.
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 4279
|
$7.5B |
1.5x |
11.8x |
Sino Biopharmaceutical
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 3
|
$7.3B |
1.8x |
6.9x |
Hikma Pharmaceuticals
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
£23
|
$7.3B |
2.4x |
8.9x |
Imeik Technology Development
|
China |
Biopharmaceuticals
|
CNY 183
|
$7.1B |
16.0x |
21.4x |
Lundbeck
|
Denmark |
Biopharmaceuticals,
Drug Development & Therapeutics
|
DKK 38
|
$7.0B |
N/A |
N/A |
Abbott India
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices,
Nutraceuticals & Cosmeceuticals
|
INR 28944
|
$6.9B |
9.4x |
36.4x |
Financiere de Tubize
|
Belgium |
Biopharmaceuticals
|
€143
|
$6.7B |
N/A |
N/A |
China Resources Sanjiu
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 42
|
$6.5B |
1.7x |
9.5x |
CR Pharmaceutical
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics,
Pharmacies
|
HKD 5
|
$6.4B |
0.2x |
2.9x |
Yuhan
|
South Korea |
Biopharmaceuticals,
Drug Development & Therapeutics
|
KRW 120524
|
$6.3B |
4.3x |
71.1x |
Biocon
|
India |
Biopharmaceuticals,
Contract Research & Manufacturing
|
INR 322
|
$6.0B |
3.5x |
17.5x |
Alkem Laboratories
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
INR 4601
|
$6.0B |
4.0x |
20.3x |
CSPC Pharma Group
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 5
|
$5.9B |
1.4x |
5.7x |
Kelun-Biotech
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 213
|
$5.8B |
23.2x |
-184.3x |
PharmaEssentia
|
Taiwan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
TWD 640
|
$5.7B |
17.8x |
164.8x |
Shanghai RAAS
|
China |
Biopharmaceuticals
|
CNY 7
|
$5.7B |
4.6x |
13.7x |
Kyowa Kirin
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 2064
|
$5.5B |
1.7x |
7.0x |
Aspen Pharmacare
|
South Africa |
Biopharmaceuticals,
Drug Development & Therapeutics
|
ZAR 173
|
$5.4B |
2.2x |
8.3x |
Wuxi XDC
|
Hong Kong |
Contract Research & Manufacturing,
Biopharmaceuticals
|
HKD 38
|
$5.3B |
10.2x |
34.6x |
Alkermes
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$35
|
$5.1B |
3.3x |
11.9x |
Chemical Works of Gedeon
|
Hungary |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HUF 10700
|
$5.1B |
2.2x |
6.0x |
Amneal Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$8
|
$5.0B |
1.8x |
7.9x |
Changchun High-Tech
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 98
|
$4.8B |
2.4x |
6.7x |
Beijing Tiantan
|
China |
Biopharmaceuticals
|
CNY 20
|
$4.8B |
5.7x |
13.6x |
Alvotech
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$12
|
$4.8B |
9.9x |
33.0x |
Amoytop Biotech
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 86
|
$4.7B |
11.7x |
32.9x |
Ono Pharmaceutical
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 1558
|
$4.7B |
1.4x |
6.0x |
Krka
|
Slovenia |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€164
|
$4.7B |
2.3x |
8.6x |
GSK India
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies,
Health & Beauty
|
INR 2509
|
$4.6B |
10.8x |
36.2x |
Bachem
|
Switzerland |
Chemicals,
Biopharmaceuticals
|
CHF 59
|
$4.6B |
6.6x |
22.7x |
Yili Chuannig Biotech
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 13
|
$4.3B |
5.2x |
N/A |
Glenmark Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1300
|
$4.2B |
2.7x |
15.6x |
Hualan Biological Engineering
|
China |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
CNY 16
|
$3.9B |
5.4x |
14.0x |
ADMA Biologics
|
United States of America |
Biopharmaceuticals
|
$16
|
$3.8B |
8.8x |
22.0x |
Hypera
|
Brazil |
Biopharmaceuticals,
Drug Development & Therapeutics
|
BRL 20
|
$3.5B |
2.7x |
9.2x |
Scholar Rock
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$38
|
$3.5B |
902.1x |
-14.2x |
Shanghai Junshi
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 27
|
$3.3B |
12.1x |
-27.5x |
Kalbe Farma
|
Indonesia |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
IDR 1220
|
$3.2B |
1.6x |
10.9x |
Dottikon ES Holding
|
Switzerland |
Chemicals,
Biopharmaceuticals
|
CHF 212
|
$3.1B |
7.6x |
24.3x |
Bora Pharmaceuticals
|
Taiwan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Contract Research & Manufacturing
|
TWD 873
|
$3.1B |
5.1x |
22.8x |